Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control.
Gideon HP, Hughes TK, Tzouanas CN, Wadsworth MH 2nd, Tu AA, Gierahn TM, Peters JM, Hopkins FF, Wei JR, Kummerlowe C, Grant NL, Nargan K, Phuah JY, Borish HJ, Maiello P, White AG, Winchell CG, Nyquist SK, Ganchua SKC, Myers A, Patel KV, Ameel CL, Cochran CT, Ibrahim S, Tomko JA, Frye LJ, Rosenberg JM, Shih A, Chao M, Klein E, Scanga CA, Ordovas-Montanes J, Berger B, Mattila JT, Madansein R, Love JC, Lin PL, Leslie A, Behar SM, Bryson B, Flynn JL, Fortune SM, Shalek AK.
Immunity. 2022 May 10;55(5):827-846.e10. doi: 10.1016/j.immuni.2022.04.004. Epub 2022 Apr 27.
Asbestos exposure and tuberculous pleurisy as developmental causes of progressive unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis.
Sekine A, Hagiwara E, Iwasawa T, Otoshi R, Erina T, Shintani R, Okabayashi H, Ikeda S, Oda T, Okuda R, Kitamura H, Baba T, Komatsu S, Ogura T.
Respir Investig. 2021 Nov;59(6):837-844. doi: 10.1016/j.resinv.2021.05.010. Epub 2021 Jun 23.
High prevalence of upper lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis in patients with round atelectasis.
Sekine A, Hagiwara E, Oda T, Muraoka T, Iwasawa T, Ikeda S, Okuda R, Kitamura H, Baba T, Takemura T, Matsumura M, Okudela K, Kumagai E, Chiba S, Motobayashi Y, Ogura T.
Respir Investig. 2023 Nov;61(6):738-745. doi: 10.1016/j.resinv.2023.08.001. Epub 2023 Sep 13.
Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases.
Shchepikhin EI, Shmelev EI, Ergeshov AE, Zaytseva AS, Shergina EA, Adamovskaya E.
Ter Arkh. 2023 Apr 26;95(3):230-235. doi: 10.26442/00403660.2023.03.202073.
The association between adipokines and pulmonary diseases: a mendelian randomization study.
Wu D, Wang Z, Wang K, Wang Y, Wang T.
BMC Pulm Med. 2024 Jan 23;24(1):50. doi: 10.1186/s12890-024-02863-8.
OPEN LUNG BIOPSY.
DELARUE NC, STRANGWAY DW.
Can Med Assoc J. 1964 Aug 8;91(6):271-81.
Diagnostic Power of the CD4+/CD8+ Ratio and the Expression of Activation and Memory Markers in Differentiating Sarcoidosis from Tuberculosis, Idiopathic Pulmonary Fibrosis, and Other Interstitial Lung Diseases.
El Fakihi S, El Allam A, Tahoune H, Kadi C, Ibrahimi A, Bourkadi JE, Seghrouchni F.
Crit Rev Immunol. 2025;45(2):77-89. doi: 10.1615/CritRevImmunol.2025056518.
The bronchoalveolar lavage fluid CD44 as a marker for pulmonary fibrosis in diffuse parenchymal lung diseases.
Suchankova M, Zsemlye E, Urban J, Baráth P, Kohútová L, Siváková B, Ganovska M, Tibenska E, Szaboova K, Tedlova E, Juskanic D, Kluckova K, Kardohelyova M, Moskalets T, Ohradanova-Repic A, Babulic P, Bucova M, Leksa V.
Front Immunol. 2025 Jan 13;15:1479458. doi: 10.3389/fimmu.2024.1479458. eCollection 2024.
Apical localization of pulmonary tuberculosis, chronic pulmonary histoplasmosis, and progressive massive fibrosis of the lung.
Goodwin RA, Des Prez RM.
Chest. 1983 May;83(5):801-5. doi: 10.1378/chest.83.5.801.
Fibrogenesis in granulomas and lung interstitium in tuberculous inflammation in mice.
Shkurupiy VA, Kim LB, Potapova OV, Cherdantseva LA, Putyatina AN, Nikonova IK.
Bull Exp Biol Med. 2014 Apr;156(6):731-5. doi: 10.1007/s10517-014-2435-y. Epub 2014 May 3.
